KR101038510B1 - prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines - Google Patents

prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines Download PDF

Info

Publication number
KR101038510B1
KR101038510B1 KR1020090003498A KR20090003498A KR101038510B1 KR 101038510 B1 KR101038510 B1 KR 101038510B1 KR 1020090003498 A KR1020090003498 A KR 1020090003498A KR 20090003498 A KR20090003498 A KR 20090003498A KR 101038510 B1 KR101038510 B1 KR 101038510B1
Authority
KR
South Korea
Prior art keywords
milliliters
alcohol
hours
water bath
filtrate
Prior art date
Application number
KR1020090003498A
Other languages
Korean (ko)
Other versions
KR20100084069A (en
Inventor
양재헌
김대근
김희자
두은철
Original Assignee
김희자
우석대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김희자, 우석대학교 산학협력단 filed Critical 김희자
Priority to KR1020090003498A priority Critical patent/KR101038510B1/en
Publication of KR20100084069A publication Critical patent/KR20100084069A/en
Application granted granted Critical
Publication of KR101038510B1 publication Critical patent/KR101038510B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/51Concentration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용 농축시럽의 제조에 관한 것으로 좀 더 상세하게는 감초를 주약제로 하고 인삼, 복령, 생지황, 생강 및 대조를 배합하여 추출 및 가수분해 시켜 생약 중에 함유되어 있는 다당체 성분을 비당체로 전환시켜 줌으로써 소화관 흡수능력을 높이고 소염 및 진통효과의 증강, 항산화작용의 증진, 체력보강, 면역 기능을 강화 시킬 뿐 아니라 보관 중 변질 및 미생물 오염을 방지시킬 수 있는 내복용 농축 시럽의 제조 방법이다.The present invention relates to the preparation of an oral concentrated syrup containing a hydrolyzed extract of licorice and its complex herbal medicine, and more particularly, extract and hydrolysis by combining ginseng as a main agent, ginseng, bokyeong, raw sulfur, ginger and control. By converting the polysaccharides contained in herbal medicines into non-sugars, it enhances digestive tract absorption, enhances anti-inflammatory and analgesic effects, enhances antioxidant activity, strengthens stamina and immune function, and prevents deterioration and microbial contamination during storage. It is a method for producing an internally prepared concentrated syrup.

감초, 가수분해 추출물, 흡수능력 개선, 생옥고 Licorice, hydrolyzed extract, absorption ability improvement

Description

감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법{prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines}Preparation of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines}

본 발명은 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법에 관한 것으로, 더욱 상세하게는 각종 환경공해와 어려운 경제여건 속에서 사회생활을 영위하면서 필연적으로 겪을 수밖에 없는 피로의 축적, 강박 관념, 정신적 긴장, 불안감, 감정의 손상, 소화기능장애, 수면장애 및 면역기능의 저하로 인하여 발생된 각종 순환기 질환, 소화기 질환, 퇴행성 질환의 염증 및 통증에 예방 및 개선 효과가 알려져 있는 한방 생약들 중 감초를 주약으로 하고 인삼, 복령, 생지황, 생강 및 대조를 복합하여 가수분해추출물로 제조함으로써 위장관 흡수능력을 촉진시키고 체력을 보강하며 각종 염증을 개선하고 간장보호 및 해독작용, 콜레스테롤 저하작용, 순환기질환 예방 및 개선 효과를 나타낼 수 있는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법에 관한 것이다.The present invention relates to a method for producing concentrated syrup for internal use containing a hydrolyzed extract of licorice and its complex herbal medicine. More particularly, fatigue inevitably suffers inevitably with social life under various environmental pollution and difficult economic conditions. Prevention and improvement of various circulatory diseases, digestive disorders, degenerative diseases, inflammation and pain caused by accumulation, obsession, mental tension, anxiety, emotional damage, digestive problems, sleep disorders and decreased immune function Among Chinese herbal medicines, licorice is the main ingredient, and ginseng, Bokryeong, raw sulfur, ginger, and control compound are manufactured as hydrolyzed extracts to promote gastrointestinal absorption ability, strengthen physical strength, improve various inflammation, protect liver, detoxification, cholesterol Licorice and its combined herbal medicines that can have a lowering effect, prevent and improve circulatory diseases It relates to a concentrated syrup production process of my taking containing decomposition extract.

대한민국 공개특허공보번호 제10-2005-0108415호Republic of Korea Patent Publication No. 10-2005-0108415

대한민국 공개특허공보번호 제10-2006-0134057호Republic of Korea Patent Publication No. 10-2006-0134057

일반적으로 생강감초탕, 경옥고는 체력의 보강, 각종 염증의 개선, 간장보호와 해독작용, 순환기질환 예방 및 개선 효과를 위하여 사용되고 있다.In general, Ginger Gumcho-tang and Kyungokgo are used for reinforcing physical strength, improving various inflammations, protecting and detoxifying the liver, and preventing and improving circulatory diseases.

특히, 생강감초탕은 감초를 위시하여 인삼, 생강 및 대조로 처방되어 한방에서 사용되어 왔으며, 이러한 생강감초탕은 심근세포에 공급되는 영양부족으로 심근의 수축력이 원활하지 못하고 기관지 및 폐의 면역기능 저하, 구강과 기관지의 진액이 부족하여 입술에 침이 잘 고이거나 인후와 구강의 건조, 기침과 천식 및 가슴이 답답할 때 심근세포, 구강, 기관지, 폐점막에 영양을 공급하며 점막을 원활하게 하여 면역기능을 강화하기 위한 것이다.In particular, ginger persimmon tang has been used in herbal medicine, including ginseng, ginger and control, including licorice, and these ginger persimmon tang is lack of nutrition supplied to cardiomyocytes, myocardial contractility is not smooth, and bronchial and lung immune functions Degradation, lack of fluid in the oral cavity and bronchus, nourish the cardiomyocytes, oral cavity, bronchial mucous membranes and smooth the mucous membranes when the saliva is well on the lips, dry throat and mouth, cough and asthma and chest tightness. To boost immune function.

또한, 경옥고는 인삼을 위시하여 복령, 생지황 및 벌꿀로 처방되어 정력과 체력을 보강하고 면역기능을 강화하며 위장 및 순환기질환에 탁월한 효능을 나타냄으로써 민간요법으로 오랜 기간 보약으로 취급되어 왔다. In addition, gyeongokgo has been treated as a folk remedy as a folk remedy for a long period of time, including ginseng, bokyeong, raw sulfur and honey are prescribed to strengthen stamina and stamina, enhance immune function, and show excellent efficacy in gastrointestinal and circulatory diseases.

그러나, 감초를 위시하여 인삼, 복령, 생지황, 생강 및 대조 등 구성생약들을 복합한 후 상기 생강감초탕 또는 경옥고를 제조하기 위하여 열탕으로 추출하거나 숙성시킬 경우에는, 수많은 활성성분과 보조성분들이 복잡하게 반응하여 침전 및 응집물을 생성시키고 유효성분이 불활성화 됨으로써 개별생약이 나타낼 수 있는 약리적인 효능을 현저하게 떨어뜨리게 되는 문제점이 발생하였다.However, in the case of extracting or aging with boiling water to produce the ginger persimmon tang or gyokgo, after combining constituent herbs such as ginseng, bokyeong, raw jihwang, ginger and control, including licorice, many active and auxiliary ingredients are complicated Reaction produced precipitates and aggregates, and the active ingredient was inactivated, which significantly lowered the pharmacological efficacy of the individual herb.

본 발명은 한방에서 체력을 보강하고 혈액순환을 촉진시키며 면역기능을 높여주고 모든 세포에 영양을 공급하며 뇌세포를 활성화하여 정신작용을 증진시키는 효능을 나타냄으로써 한방 및 민간요법으로 오랫동안 사용되어 온 경옥고와, 심근세포에 영양을 공급함으로써 심근의 수축력을 높이고 기관지 및 폐의 기능을 강화시켜주며 혈액순환을 촉진시키고 위액 분비를 항진하여 소화기능을 높여주는 생강감초탕의 구성생약을 배합하여, 복잡하고 비과학적인 제조방법을 개선하고 유효성분의 추출효율을 높여주며 원료생약의 보관 및 제조과정에서 변질 및 미생물 오염을 방지시킴으로써 혈액순환촉진, 소화기능개선, 위장보호, 기관지 손상예방, 체력보강 및 면역기능강화 등의 효능을 극대화 시킬 수 있는 제조방법을 개발하고자 한다.The present invention has been used for a long time in oriental medicine and folk remedies by showing the effect of strengthening stamina in the oriental medicine, promoting blood circulation, enhancing immune function, nourishing all cells, and activating brain cells to promote mental function Whey, nutrients to the myocardial cells to increase the contractile power of the myocardium, strengthen the function of the bronchial and lungs, promote blood circulation and promote the secretion of gastric juice secretion by combining the constituents of ginger persimmon tang to enhance digestion Improves unscientific manufacturing methods, improves the extraction efficiency of active ingredients, prevents alteration and microbial contamination during the storage and manufacturing of raw materials, thereby promoting blood circulation, improving digestive function, gastrointestinal protection, preventing bronchial damage, strengthening stamina and immune function To develop a manufacturing method that can maximize the efficacy, such as strengthening.

본 발명에 따른 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법에 의하면, 피로의 축적, 정신적 긴장, 불안감, 감정의 손상, 소화기능 장애, 수면 장애 및 면역 기능저하로 인하여 발생된 각종 순환기 질환, 소화기 질환, 퇴행성 질환의 염증 및 통증에 예방 및 개선 효과가 알려져 있는 한방 생약들 중 감초를 주약으로 하고, 인삼, 복령, 생지황, 생강 및 대조를 복합하여 가수분해추출물로 제조함으로써, 유효성분의 흡수 능력을 높이고 소화기능을 촉진시키며 체력보강, 면역기능 향상, 간장 보호 및 해독작용, 콜레스테롤 저하작용, 순환기질환 예방 및 개선 효과가 발생한다.According to the method for producing concentrated syrup for internal use containing the hydrolyzed extract of licorice and its complex herbal according to the present invention, fatigue accumulation, mental tension, anxiety, emotional damage, digestive dysfunction, sleep disorders and immune deterioration Among the herbal medicines that are known to prevent and improve the inflammation and pain of various circulatory diseases, digestive diseases, and degenerative diseases, the licorice is the main ingredient, and ginseng, Fukryeong, Saenghwanghwang, ginger, and the control are combined into hydrolyzed extracts. By manufacturing, it increases the absorption ability of the active ingredient, promotes digestive function, strengthens stamina, improves immune function, protects and detoxifies liver, lowers cholesterol, prevents and improves circulatory diseases.

상기와 같은 목적을 달성하기 위한 본 발명이 응용하려한 생강감초탕은 감초를 위시하여 인삼, 생강 및 대조로 처방되어 한방에서 사용되어 왔다. 심근세포에 공급되는 영양부족으로 심근의 수축력이 원활하지 못하고 기관지 및 폐의 면역기능이 저하되어 있고, 구강과 기관지의 진액이 부족하여 입술에 침이 잘 고이거나 인후와 구강이 건조하고, 기침과 천식이 있으며, 가슴이 답답할 때 심근세포, 구강, 기관지, 폐점막에 영양을 공급하며 점막을 원활하게 하여 면역기능을 강화한다. Ginger licorice tang to be applied to the present invention for achieving the above object has been used in herbal medicine prescribed by ginseng, ginger and control including licorice. Due to malnutrition supplied to cardiomyocytes, myocardial contractility is not smooth, bronchial and lung immune functions are deteriorated, oral and bronchial fluid is lacking. Asthma, when the chest is stuffy, nourish the cardiomyocytes, mouth, bronchus, pulmonary mucosa and smooth the mucous membranes to enhance immune function.

경옥고는 인삼을 위시하여 복령, 생지황 및 벌꿀로 처방되어 정력과 체력을 보강하고 면역기능을 강화하며 위장 및 순환기질환에 탁월한 효능을 나타냄으로써 민간요법으로 오랜 기간 보약으로 취급되어 왔다.Gyungokgo has been treated as a folk remedy for a long time as ginseng, including Bokryeong, Saenghwang and Honey, which is prescribed as a folk remedy by reinforcing stamina and stamina, enhancing immune function, and showing excellent effects on gastrointestinal and circulatory diseases.

본 발명은 제조방법이 힘들고 까다로운 상기 생강감초탕과 경옥고의 구성 생약을 각각 가수분해추출 및 발효법으로 제조하여 생약 중에 함유되어있는 다당체성분을 비당체로 전환시켜줌으로써 유효성분의 흡수능력을 증진시키고 변질 및 미생물 오염을 최대한으로 방지시키고자 하였다.The present invention is prepared by the hydrolysis extraction and fermentation method of the constituent herbs of ginger persimmon tang and cheongogo respectively difficult and difficult to manufacture by converting the polysaccharide component contained in the herbal medicine to non-saccharides to enhance the absorption capacity of the active ingredient and deterioration And microbial contamination to the greatest extent possible.

특히 생약 중에 함유된 활성성분의 효능을 관찰해 보면,In particular, when observing the efficacy of the active ingredient contained in the herbal medicine,

첫째, 감초에 함유된 Glycyrrhizin(글리시리진)은 항알러지작용, NK세포(Natural Killer cell) 활성화작용, 인터페론 생성, 해열작용을 가지며, 위산분비를 억제하고 위점막을 보호함으로써 항 궤양작용을 나타낸다.First, Glycyrrhizin (glycirrhizin) contained in licorice has anti-allergic effect, NK cell activation, interferon production, antipyretic effect, and anti-ulcer activity by inhibiting gastric acid secretion and protecting gastric mucosa.

Glycyrrhetic acid(글리시레틴 산)은 스테로이드 호르몬과 같은 작용을 가짐 으로써 항염증작용, 해독작용, 해열작용, 소화기 평활근 경련 억제, 간 손상 억제 작용을 나타내며, Phospholipase A2(포스포리파아제 A2)의 활성을 억제하고 Prostaglandin(프로스타글란딘) 생성을 저해하여 진통작용을 나타낼 뿐 아니라 기관지평활근 경련을 억제하여 진해작용 및 진경작용을 나타낸다. Glycyrrhetic acid has anti-inflammatory, detoxification, antipyretic, gastrointestinal smooth muscle spasms and liver damage inhibitory effects by having steroid hormone-like action, and inhibits the activity of Phospholipase A2 (phospholipase A2). It inhibits Prostaglandin (prostaglandin) production and exhibits analgesic activity, as well as suppresses bronchial smooth muscle spasms, thereby showing antitussive and myocardial action.

LH-1은 면역세포를 활성화하고 Macrophage(대식세포) 탐식능을 강화시키며 면역기억세포의 생성을 촉진하고, 심근세포에 영양을 공급하여 심장의 기외 수축을 완화하며 심장운동능을 정상화 시킨다.LH-1 activates immune cells, enhances macrophage phagocytosis, promotes the production of immune memory cells, nourish cardiomyocytes, relieves cardiac contractions and normalizes cardiomotor activity.

Ligustrazine(리구스트라진)은 항염작용을 가지고 있고, β-Amyrin(β-아미린)은 항균작용 및 항바이러스작용을 가짐으로써 황색포도상구균, 결핵간균에 대한 항균작용 및 항종양 작용을 나타낸다.Ligustrazine has anti-inflammatory activity, and β-Amyrin has antibacterial and antiviral effects, indicating antibacterial and anti-tumor activity against Staphylococcus aureus and Mycobacterium tuberculosis.

둘째, 인삼에 함유된 Ginsenoside Rg1,Re,Rb2(인삼배당체 Rg1,Re,Rb2)는 부신피질기능을 강화하고 면역세포 생성을 촉진하여 면역기능을 증강시키고, Ginsenoside Rb1,Re 및 Adenosine(아데노신)은 혈중의 중성지방 생성을 저하시키며, Ginsenoside Rg2, Rg3은 혈소판응고를 저해하여 혈전생성을 방지한다. Second, Ginsenoside Rg1, Re, Rb2 (Ginseng Glycoside Rg1, Re, Rb2) contained in ginseng enhances adrenal cortex function and promotes immune cell production to enhance immune function, while Ginsenoside Rb1, Re and Adenosine (adenosine) It lowers the production of triglycerides in blood, and Ginsenoside Rg2 and Rg3 inhibit platelet coagulation and prevent thrombus formation.

Ginsenoside Rb1은 혈소판응고 억제작용이 있어서 인삼을 상복하면 뇌혈전이 예방되고 지방간의 지질분해작용을 가지고 있어 알코올 과음으로 인한 지방간의 예방과 치료에 사용하며, Cholesterol(콜레스테롤) 혈증을 저하하고 임파구의 활성을 촉진하여 면역기능을 증강시키며, 진정작용이 있어 신경을 안정시키고 불면증을 개선한다. Ginsenoside Rb1 has a platelet coagulation inhibitory effect, which prevents cerebral thrombosis, and has a lipolytic effect of fatty liver, which is used for the prevention and treatment of fatty liver due to alcohol drinking.It decreases Cholesterol (hypocholesterol) emia and activity of lymphocytes. Promotes immunity by promoting sedation and stabilizes nerves and improves insomnia.

Ginsenoside Rb2는 암세포 증식을 억제하고, Ginsenoside Rb2,Re,Rg1은 골수 세포의 단백질합성과 지질합성 및 적혈구 생성을 촉진하여 체력을 강화한다. Saponin(사포닌)은 신경의 흥분전도를 가속화하고 조건반사능을 신속하게 하여 피로를 경감시키고 작업능률을 높이는 것으로 보고되어 있다. Ginsenoside Rb2 inhibits cancer cell proliferation and Ginsenoside Rb2, Re, Rg1 enhances stamina by promoting protein synthesis, lipid synthesis and red blood cell production of bone marrow cells. Saponin has been reported to accelerate fatigue and accelerated condition reflexes to reduce fatigue and increase work efficiency.

한편 여러 종류의 아미노산과 함께 Vitamin B12(비타민 B12) 및 Folic acid(엽산)등이 함유되어 있어 세포에 영양을 공급하고 빈혈을 개선한다.On the other hand, it contains vitamin B12 (vitamin B12) and folic acid (folic acid) together with various kinds of amino acids to nourish cells and improve anemia.

셋째, 복령에 함유되어 있는 β-Pachymose(β-파키모스), Pachymic acid(파키믹 산), Lecithin(레시틴), 단백질, 지방, 칼륨등은 뇌세포를 활성화하여 정신을 안정시키며, 모든 세포에 영양을 공급하여 허약체질을 개선하며, Pachyman(파키만) 및 Pachymose(피키모스)등의 다당체는 면역기능을 증강시키고 항종양작용을 나타내는 것으로 알려져 있다. Choline(콜린)은 혈중지질분해를 촉진시키고 Acethylcholine(아세틸콜린)으로 생합성 되어 뇌세포를 활성화한다.Third, β-Pachymose (β-Pachimos), Pachymic acid, Lecithin, Lecithin, protein, fat, potassium, etc. contained in Bokryeong activate brain cells and stabilize the mind. It provides nutrition to improve weakness, and polysaccharides such as Pachyman and Pachymose are known to enhance immune function and exhibit antitumor activity. Choline promotes blood lipid degradation and is biosynthesized with Acethylcholine (acetylcholine) to activate brain cells.

넷째, 생지황에 함유된 Catalpol(카탈폴)은 혈당강하작용을 가지고 있고, Adenosine(아데노신)이 항혈전작용, 항류마티스작용을 나타내며, 철분은 조혈작용과 함께 허혈을 개선하고 신장혈류를 증진하여 이뇨를 증가시키고 관절의 부종 및 동통을 경감시킨다.Fourth, Catalpol (catalpol) contained in the live diabetes has a hypoglycemic action, Adenosine (adenosine) exhibits anti-thrombotic action, anti-rheumatic effect, iron with hematopoietic action to improve ischemia and promote renal blood flow diuretic Increase and relieve joint swelling and pain.

다섯째, 생강에 함유된 6-Gingerol(6-진저롤)은 프로스타글란딘 합성 억제작용, 항궤양작용, 간독성 해독작용, 담즙분비 촉진작용, 심장기능 강화작용을 하며, Zingerol(진저롤)이 혈관운동중추를 강화하여 혈액순환을 촉진하고 소화액 분비를 항진하여 소화를 촉진하는 것으로 알려져 있다. Shogaol(쇼가올)은 간독성 해독작용을 가지고 있고, Acetaldehyde(아세트알데히드)는 진통작용 및 진경작용을 가지 고 있으며 신장사구체 혈류량을 증가시켜 이뇨작용을 나타낸다. Furfural(푸르푸랄)은 점막자극작용을 가지고 있고, Caffeic acid(카페인산)는 혈중지질 저하작용을 나타낸다. 한편 생강의 특이취를 나타내는 Allylmethyl sulfide(알릴메칠 설파이드), Isopropyl sulfide(이소프로필 설파이드) 및 Diethyl sulfide(디에칠 설파이드)는 항균작용을 가지고 있는 것으로 알려져 있다.Fifth, 6-Gingerol (6-Gingerol) contained in Ginger inhibits prostaglandin synthesis, anti-ulcer, hepatotoxic detoxification, bile secretion and cardiac function, and Zingerol (Gingerol) strengthens the vascular locomotor center. It is known to promote blood circulation and promote digestion by promoting digestion. Shogaol has a hepatotoxic detoxification action, and Acetaldehyde has analgesic and mycelial action and diuretic effect by increasing renal glomerular blood flow. Furfural has a mucosal irritant effect and Caffeic acid has a hypolipidemic effect. Allylmethyl sulfide, allylmethyl sulfide, isopropyl sulfide, and diethyl sulfide, which are specific to ginger, are known to have antimicrobial activity.

여섯째, 대조에는 당류, 칼슘, 비타민 C, 단백질, 지방 등이 풍부하여 세포에 영양을 공급하고 대사를 활성화한다. Ethyl-α-D-Fufuctofuranoside(에칠알파디후룩토후라노시드)는 Cyclic AMP(사이클릭 AMP)를 증가시켜 항알러지작용을 나타내고, Nornuciferine(노르누씨페린)은 강력한 최면작용과 진경작용을 가지고 있다. Oxonuciferine(옥소노르누씨페린)는 최면작용을 가지고 있고 C-AMP는 비만세포막을 강화하여 항알러지작용을 나타내며 소변의 배설을 촉진시킨다. Maslinic acid(마스리닌산)는 항염작용을 가지고 있으며 히스타민에 의한 장 경련을 억제하고 스트레스성 궤양을 막아주며 진경작용을 나타낸다.Sixth, the control is rich in sugars, calcium, vitamin C, proteins, fats, etc. to nourish cells and activate metabolism. Ethyl-α-D-Fufuctofuranoside increases anti-allergic effect by increasing Cyclic AMP, and Nornuciferine has strong hypnosis and hardening effect. . Oxonuciferine has hypnotic action and C-AMP strengthens the mast cell membrane to show anti-allergic action and promote urine excretion. Maslinic acid has anti-inflammatory properties, inhibits histamine-induced bowel spasms, prevents stress ulcers, and exhibits antifungal activity.

상기의 목적을 달성하기 위하여 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법은 아래와 같은 실시예들에 의해 달성되며, 구성비율은 본 발명에 해당되는 것이고, 구성량에 대해서는 ± 10% 범위에서 실시가 가능하다.In order to achieve the above object, a method for preparing an oral concentrated syrup containing a hydrolyzed extract of licorice and its complex herbal medicine is achieved by the following examples, and the constituent ratio corresponds to the present invention, Can be implemented in the range of ± 10%.

제 1실시예;First embodiment;

감초 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of licorice, add 500 milliliters of 70% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ° C in a water bath, filter with filter paper, and collect the filtrate. 300 ml of purified water and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃;

인삼 600그램에 70% 알코올 800밀리리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 400밀리리터 및 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;800 ml of 70% alcohol and 40 milliliters of 1% hydrochloric acid were added to 600 g of ginseng, warmed at 50-60 ℃ for 4 hours in a water bath, filtered through a filter paper, and the filtrate was collected. 400 ml of purified water and enzyme solution Adding 20 milliliters and fermenting at 28-32 ° C. for 30 days;

복령 1.0킬로그램에 70% 알코올 1.2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 800밀리리터 및 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;1.2 kg of 70% alcohol and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, heated in a water bath at 50-60 ° C. for 4 hours, filtered through a filter paper, and the filtrate was taken. 800 ml of purified water and an enzyme solution were obtained. Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days;

생지황 1.6킬로그램에 70% 알코올 2.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 1리터 및 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kg of raw sulfur, 2.2 liters of 70% alcohol and 110 milliliters of 1% hydrochloric acid were added and warmed in a water bath at 50-60 ° C. for 4 hours, filtered through a filter paper, and the filtrate was taken. Then, 1 liter of purified water and 50 milliliters of enzyme solution were added. Fermentation at 30 ° C. for 30 days;

생강 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, add 500 milliliters of 70% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ℃ in a water bath, filter with filter paper, filter the filtrate, and add 300 milliliters of purified water and 15 milliliters of enzyme solution. Fermentation at 30 ° C. for 30 days;

대조 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;500 milliliters of 70% alcohol and 25 milliliters of 1% hydrochloric acid were added to 400 grams of control. The mixture was warmed at 50 to 60 DEG C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was collected. 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃;

위에서 각각 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 하였다.Licorice, Ginseng, Bokyeong, Saenghwanghwang, Ginger, and the control solution, each extracted and fermented with alcohol solution from above, are mixed in one container and warmed at 80-90 ℃ for 4 hours in a water bath to completely volatilize the alcohol components, The concentrate was filled into an airtight container to obtain a final product.

효소용액 ; β-glucuronidase(베타글루쿠로니다제) 50,000unit(역가)를 취하고 정제수를 넣어 100밀리리터로 한다.Enzyme solution; Take 50,000 units of β-glucuronidase (betaglucuronidase) and add 100 ml of purified water.

제 2실시예;Second embodiment;

감초 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of licorice, add 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50 ~ 60 ℃ in a water bath, filter with filter paper, take filtrate, add 15ml of enzyme solution, and add 30ml at 28∼32 ℃. Fermentation during;

인삼 600그램에 35% 알코올 1.2리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 600 grams of ginseng, 1.2 liters of 35% alcohol and 40 milliliters of 1% hydrochloric acid were added and warmed at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. Adding 20 milliliters and fermenting at 28-32 ° C. for 30 days;

복령 1.0킬로그램에 35% 알코올 2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;2 kg of 35% alcohol and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days;

생지황 1.6킬로그램에 35% 알코올 3.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kilograms of raw sulfur, 3.2 liters of 35% alcohol and 110 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 50 milliliters of the fermentation for 30 days at 28 ~ 32 ℃;

생강 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, add 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ℃ in a water bath, filter with filter paper, take filtrate, add 15 milliliters of enzyme solution, and add 30ml at 28-32 ℃. Fermentation during;

대조 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계; To 400 grams of control, add 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50 ~ 60 ℃ in water bath, filter with filter paper, take filtrate, add 15ml of enzyme solution, and add 30ml at 28∼32 ℃. Fermentation during;

위에서 각각 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 제조하였다.Licorice, Ginseng, Bokyeong, Saenghwanghwang, Ginger, and the control solution, each extracted and fermented with alcohol solution from above, are mixed in one container and warmed at 80-90 ℃ for 4 hours in a water bath to completely volatilize the alcohol components, The concentrate was filled into an airtight container to prepare a final product.

제 3실시예;Third embodiment;

감초 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of licorice, 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid were added and warmed at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 300 milliliters of 95% alcohol and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃;

인삼 600그램에 정제수 800밀리리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 400밀리리터 및 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 600 grams of ginseng, 800 milliliters of purified water and 40 milliliters of 1% hydrochloric acid were added, warmed for 4 hours at 50-60 ° C in a water bath, filtered through a filter paper, and the filtrate was taken. 400 milliliters of 95% alcohol and enzyme solution Adding 20 milliliters and fermenting at 28-32 ° C. for 30 days;

복령 1.0킬로그램에 정제수 1.2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 800밀리리터 및 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;1.2 kg of purified water and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, warmed at 50-60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 800 ml of 95% alcohol and enzyme solution Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days;

생지황 1.6킬로그램에 정제수 2.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 1리터 및 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kilograms of fresh sulfur, 2.2 liters of purified water and 110 milliliters of 1% hydrochloric acid were added, heated at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 1 liter of 95% alcohol and an enzyme solution were added. 50 milliliters of the fermentation for 30 days at 28 ~ 32 ℃;

생강 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 300 milliliters of 95% alcohol and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃;

대조 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of control, 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 300 milliliters of 95% alcohol and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃;

위에서 각각 정제수 및 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 제조하였다.Licorice, Ginseng, Bokryeong, Saengjihwang, Ginger, and the control solution, which were extracted and fermented with purified water and alcohol solution from above, were all mixed in one container and warmed at 80-90 ° C. for 4 hours in a water bath to completely evaporate the remaining alcohol. The herbal complex concentrate was filled into an airtight container to prepare a final product.

이하 본 발명에 따른 추출물 또는 발효 및 가수분해물의 작용 및 실험결과에 대해 설명한다. Hereinafter will be described the action and experimental results of the extract or fermentation and hydrolyzate according to the present invention.

1. 감초 및 그 가수분해물의 확인 및 정량1. Identification and Quantification of Licorice and Its Hydrolysates

감초의 주성분인 Glycyrrhizin(글리시리진)과 그 가수분해물인 Glycyrrhetinic acid(글리시레틴 산)의 함량은 HPLC 분석방법을 응용하여 실험하였고 그 조건은 다음과 같다.The contents of Glycyrrhizin (glycyrrhizin), the major component of licorice, and Glycyrrhetinic acid (glycyrrhitin acid), its hydrolyzate, were tested by HPLC analysis. The conditions were as follows.

Glycyrrhizin ;Glycyrrhizin;

Column; Nucleosil C18 (4.0 × 250 mm)Column; Nucleosil C 18 (4.0 × 250 mm)

Mobile phase; the mixture of HOH ; CH3CN ; AcOH (560.0 ; 400.0 ; 40.0 )Mobile phase; the mixture of HOH; CH 3 CN; AcOH (560.0; 400.0; 40.0)

Flow rate; 1.2 mL/minFlow rate; 1.2 mL / min

Injection volume; 20 μlInjection volume; 20 μl

Detector; UV detector (λmax = 254 nm) Detector; UV detector (λ max = 254 nm)

Glycyrrhetinic acid;Glycyrrhetinic acid;

Column;Spherisorb ODSI column C18 (4.0 × 250 mm)Column; Spherisorb ODSI column C 18 (4.0 × 250 mm)

Mobile phase; the mixture of HOH ; CH3CN ; AcOH (170.0 ; 830.0 ; 5.0 )Mobile phase; the mixture of HOH; CH 3 CN; AcOH (170.0; 830.0; 5.0)

Flow rate; 1.2 mL/minFlow rate; 1.2 mL / min

Injection volume; 20 μlInjection volume; 20 μl

Detector; UV detector (λmax = 254 nm) Detector; UV detector (λ max = 254 nm)

Glycyrrhizin(글리시리진) 및 Glycyrrhetinic acid(글리시레틴 산)의 함량 분석 결과 Analysis of the contents of Glycyrrhizin and Glycyrrhetinic acid

감초의 주성분인 Glycyrrhizin(글리시리진)과 그 가수분해물인 Glycyrrhetinic acid(글리시레틴 산)의 함량을 HPLC 분석방법으로 실험한 결과, 파장 245 nm에서 Glycyrrhizin의 chromatogram을 나타내었고 검량선의 작성결과 y = 367.5x + 53.2 , R² = 0.999 이었으며 50 μg/mL까지 양호한 직선성을 나타내었다.HPLC analysis of the contents of Glycyrrhizin, a major component of licorice, and its hydrolyzate, Glycyrrhetinic acid, showed chromatograms of Glycyrrhizin at a wavelength of 245 nm. + 53.2, R² = 0.999 and good linearity up to 50 μg / mL.

[그림1] Glycyrrhizin의 HPLC 크로마토그램[Figure 1] HPLC chromatogram of Glycyrrhizin

Figure 112009002773147-pat00001
Figure 112009002773147-pat00001

Column: Nucleosil C18 (4.0 × 250 mm)Column: Nucleosil C 18 (4.0 × 250 mm)

Mobile phase: the mixture of HOH : CH3CN : AcOH(560.0 : 400.0 : 40.0)Mobile phase: the mixture of HOH: CH 3 CN: AcOH (560.0: 400.0: 40.0)

Flow rate: 1.2 mL/minFlow rate: 1.2 mL / min

Injection volume: 20 μlInjection volume: 20 μl

Detector: UV detector (λmax = 254 nm) Detector: UV detector (λ max = 254 nm)

한편 Glycyrrhetinic acid(글리시레틴 산)의 chromatogram은 파장 245nm에서 나타났고 검량선의 작성결과 y = 74.95x - 14.5, R² = 0.999 이었다.On the other hand, the chromatogram of Glycyrrhetinic acid was shown at wavelength 245nm and the calibration curve was y = 74.95x-14.5, R² = 0.999.

[그림2] Glycyrrhetinic acid의 HPLC 크로마토그램[Figure 2] HPLC chromatogram of Glycyrrhetinic acid

Figure 112009002773147-pat00002
Figure 112009002773147-pat00002

Column:Spherisorb ODSI column C18 (4.0 × 250mm)Column: Spherisorb ODSI column C 18 (4.0 × 250mm)

Mobile phase: the mixture of HOH : CH3CN : AcOH (170.0 : 830.0 : 5.0)Mobile phase: the mixture of HOH: CH 3 CN: AcOH (170.0: 830.0: 5.0)

Flow rate: 1.2 mL/minFlow rate: 1.2 mL / min

Injection volume: 20 μlInjection volume: 20 μl

Detector: UV detector (λmax = 254 nm) Detector: UV detector (λ max = 254 nm)

2. 주성분 가수분해 실험2. Principal Component Hydrolysis Experiment

1) 산에 의한 가수분해물의 제조 및 측정1) Preparation and Measurement of Hydrolysates by Acid

감초추출물을 pH1, 3, 5, 7, 9 (90% ethanol)에 용해시킨 후 40 ± 2 ℃ 에 서 2일간 반응시킨 후 각 시간별로 가수분해율을 측정하였다.The licorice extract was dissolved in pH 1, 3, 5, 7, 9 (90% ethanol) and then reacted at 40 ± 2 ° C for 2 days, and then the hydrolysis rate was measured for each hour.

2) 1% HCl(염산) , 1% NaOH(수산화나트륨), β-glucuronidase(β-글루쿠로니다제 )를 이용한 가수분해 측정2) Determination of hydrolysis using 1% HCl (hydrochloric acid), 1% NaOH (sodium hydroxide) and β-glucuronidase (β-glucuronidase)

감초추출물을 90% Ethanol 에 용해시킨 후, 1% HCl, 1% NaOH, Licorice extract was dissolved in 90% Ethanol, 1% HCl, 1% NaOH,

β-glucuronidase(베타글루쿠로니다제)를 이용하여 가수분해율을 측정하였다.Hydrolysis rate was measured using β-glucuronidase (betaglucuronidase).

3) 주성분의 가수분해율 측정결과3) Measurement result of hydrolysis rate of main component

pH 1.0 에서 가수분해에 의한 glycyrrhetinic acid(글리시레틴 산)의 증가율은 24시간 후 82.67%, 48시간 후 98.28%로 다른 pH 영역에서 실험한 군보다 높게 나타났으며, pH 9.0 에서는 가수분해는 거의 이루어지지 않았다.The increase rate of glycyrrhetinic acid by hydrolysis at pH 1.0 was 82.67% after 24 hours and 98.28% after 48 hours, higher than the group tested in other pH ranges. It was not done.

[표1]Table 1

40℃에서 90% ethanol 용액 중 여러 가지 pH 조건 하에서 Glycyrrhizin의 가수분해율 비교Comparison of Hydrolysis Rate of Glycyrrhizin at Various pH Conditions in 90% Ethanol Solution at 40 ℃

pH1pH1 pH3pH3 pH5pH5 pH7pH7 pH9pH9 24 hr24 hr 82.67±
2.41%
82.67 ±
2.41%
9.85±
2.51%
9.85 ±
2.51%
10.66±
2.55%
10.66 ±
2.55%
18.95±
1.98%
18.95 ±
1.98%
26.64±
1.37%
26.64 ±
1.37%
48 hr48 hr 98.28±
5.88%
98.28 ±
5.88%
25.44±
1.88%
25.44 ±
1.88%
13.88±
3.70%
13.88 ±
3.70%
45.30±
2.76%
45.30 ±
2.76%
73.04±
4.02%
73.04 ±
4.02%

Each data represents the mean± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

1% HCl을 이용한 가수분해율은 1% NaOH, β-glucuronidase(1000 unit(역가))을 사용하였을 때보다 2 ~ 5배 정도로 높았다.The hydrolysis rate using 1% HCl was 2-5 times higher than that of 1% NaOH and β-glucuronidase (1000 units).

[표2] [Table 2]

40℃에서 90% ethanol 용액 중 효소, 산 및 염기 조건 하에서 Glycyrrhizin의 가수분해율 비교 Comparison of Glycyrrhizin Hydrolysis Rate under Enzyme, Acid and Base Conditions in 90% Ethanol Solution at 40 ℃

B-glucuronidaseB-glucuronidase 1% HCI1% HCI 1% NaOH1% NaOH 24hr24hr 61.25±2.44%61.25 ± 2.44% 66.49± 3.56%66.49 ± 3.56% 12.5±1.55%12.5 ± 1.55% 48hr48hr 85.23±4.50%85.23 ± 4.50% 180.28±1.22%180.28 ± 1.22% 15.75±2.18%15.75 ± 2.18% 72hr72hr 118.78±3.21%118.78 ± 3.21% 240.09±4.62%240.09 ± 4.62% 24.57±1.61%24.57 ± 1.61%

Each data represents the mean± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

3. DPPH 법에 의한 항산화 실험3. Antioxidant Experiment by DPPH Method

주성분 및 히드로겔의 free radical(유리기) 소거활성은 1,1-diphenyl-2-picrylhydrazil(1,1디페닐-2-피크릴히드라질,DPPH)을 사용하였으며 먼저 0.2 mM DPPH 메탄올 용액 0.5mL에 시료를 여러 농도로 희석한 용액 1mL를 가하고 vortex mixer(와류믹서)로 10초간 진탕한 후 20℃에서 30min 간 방치한 다음 517nm에서 흡광도를 측정하였다. 비교 표준물질로는 butylated hydroxy anisole(부칠히드록시아니솔, BHA)를 사용하였다. 그 활성의 크기는 DPPH에 대한 전자공여능(Electron Donating Ability, EDA%)로 나타내었다.1,1-diphenyl-2-picrylhydrazil (1,1diphenyl-2-picrylhydrazyl, DPPH) was used for free radical scavenging activity of the main component and hydrogel. 1 mL of the solution diluted to various concentrations was added, shaken for 10 seconds with a vortex mixer, and allowed to stand at 20 ° C. for 30 min, and then absorbance was measured at 517 nm. Butyl hydroxy anisole (BHA) was used as a comparative standard. The magnitude of the activity is expressed in terms of Electron Donating Ability (EDA) for DPPH.

EDA(%) =

Figure 112009002773147-pat00003
× 100EDA (%) =
Figure 112009002773147-pat00003
× 100

Sample ABS ; 시료를 가한 시험액의 흡광도Sample ABS; Absorbance of the test solution

Control ABS ; 시료 대신 Methanol을 가한 시험액의 흡광도Control ABS; Absorbance of Test Solution Added Methanol Instead of Sample

항산화 효과 비교Antioxidant Effect Comparison

주성분의 free radical(유리기) 소거 활성은 비교해 보면, 1000μg/ml 농도에서 BHA 70.41 ± 5.20% 이었으며 감초추출물은 55.67 ± 3.89%로 비교적 높은 수소공여능을 보여주었으며 감초가수분해추출물에서는 55.05 ± 6.56으로써 감초추출물과 큰 차이를 나타내지는 않았다.The free radical scavenging activity of the main component was BHA 70.41 ± 5.20% at 1000μg / ml concentration and licorice extract showed 55.67 ± 3.89% hydrogen donating ability and 55.05 ± 6.56 in licorice hydrolyzate extract. It did not show a big difference.

[표3] [Table 3]

DPPH법에 의한 활성산소 억제효과 비교Comparison of the Inhibitory Effects of Reactive Oxygen by DPPH Method

SampleSample EDA(1000μg)EDA (1000 μg) EDA(100μg)EDA (100 μg) BHABHA
70.41±7.25

70.41 ± 7.25
67.56±3.5867.56 ± 3.58
감초추출물Licorice Extract
55.67±3.89

55.67 ± 3.89
38.11±5.1238.11 ± 5.12
감초
가수분해추출물
licorice
Hydrolysis extract

55.05±6.56

55.05 ± 6.56
32.27±7.1432.27 ± 7.14

EDA ; 수소공여능 (%) EDA; Hydrogen donating ability (%)

Each data represents the mean± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

4. 항염효과 측정실험4. Anti-inflammatory effect measurement experiment

1) 부종억제 실험1) Edema Suppression Experiment

히드로겔의 부종억제 실험은 카라기난으로 유발된 랫트 족부종에 의한 항염효과 측정방법을 응용하여 실험하였다. 부종유발은 랫트의 오른쪽 족 저부에 1% λ-carrageenan(λ-카라기난)과 1% kaolin(카올린)을 PBS(phosphate buffered saline)에 녹여 0.1mL를 주사하여 유발시켰다. 약물 도포는 유발 1시간 전에 오른 쪽 족 저부에 각각 1회씩 도포하였다.The edema suppression experiment of hydrogel was conducted by applying the anti-inflammatory effect of carrageenan-induced rat foot edema. Edema was induced by dissolving 1% λ-carrageenan (λ-carrageenan) and 1% kaolin (kaolin) in PBS (phosphate buffered saline) at the bottom of the right foot of the rat. Drug application was applied once to the bottom of the right foot each 1 hour before induction.

부종측정은 plethysmometer(부종측정기)를 이용하여 1% λ-carrageenan(카라기난)과 1% kaolin(카올린)의 투여전과 투여 후 6, 12, 24 및 48시간대에서 3회 반복측정 하여 평균값으로 하였다. 부종율은 λ-carrageenan주사 직후 및 각 시간대의 발 부피의 변화를 이용하여 다음 식으로 부종률(%, swelling) 및 부종 억제율(%, inhibition)을 산출하였다.Edema was measured using a plethysmometer and repeated three times at 6, 12, 24 and 48 hours before and after administration of 1% λ-carrageenan and 1% kaolin. The edema rate was calculated using the change of foot volume immediately after λ-carrageenan injection and at each time period. The edema rate (%, swelling) and edema inhibition rate (%, inhibition) were calculated by the following equation.

부 종 률(%) =

Figure 112009002773147-pat00004
× 100 Edema rate (%) =
Figure 112009002773147-pat00004
× 100

부종억제율(%) = [ 1 -

Figure 112009002773147-pat00005
] × 100Edema inhibition rate (%) = [1-
Figure 112009002773147-pat00005
] × 100

V 는 6, 12, 24 및 48시간 후의 발 부피이며, V1는 주사직후 발 부피, Vc 대조군의 부종률, Vd 는 처치군의 부종률이다. V is the foot volume after 6, 12, 24 and 48 hours, V 1 is the foot volume immediately after injection, and V c is Edema rate of the control group, V d is the edema rate of the treatment group.

2) 항염 효과 비교2) Comparison of anti-inflammatory effects

카라기난 유발 부종에 대한 치료계수 측정방법을 응용하여 히드로겔제의 부종 및 억제효과를 비교했을 때, 카라기난 투여 6시간 후에, 대조군에서 2.3 mL로 부종이 최대치를 나타내었고, 12시간 이후부터 부종률이 서서히 감소되기 시작하였다. 감초엑스의 부종억제 효과는 12시간 이후부터 나타나기 시작하였는데, 대조군에서 2.01 ± 0.03ml로 나타난 반면, 대조약물인 트리암시놀론에서는 1.77 ± 0.04 mL 감초엑스에서는 1.80 ± 0.23mL, 감초가수분해추출물에서는 1.75 ± 0.12ml 로 부종 억제효과에 대한 유의성을 보여주었다.When comparing the hydrogel edema and inhibitory effect by applying the treatment coefficient measurement method for carrageenan-induced edema, edema was the maximum at 2.3 mL in the control group 6 hours after carrageenan administration, and edema rate gradually after 12 hours. It began to decrease. Edema suppression effect of licorice extract began to appear after 12 hours, compared with 2.01 ± 0.03 ml in the control group, while 1.77 ± 0.04 mL in the control drug triamcinolone 1.80 ± 0.23 mL in the licorice extract, 1.75 ± 0.12 in the licorice hydrolyzate extract ml showed significant effect on the effect of suppressing edema.

[표4] Table 4

카라기난으로 유발된 흰쥐의 족부종에 대한 감초 가수분해추출물의 억제효과Inhibitory Effect of Licorice Hydrolyzate Extract on Carrageenan-Induced Foot Edema in Rats

Formulation
(㎖)
Formulation
(Ml)
Time(hr)Time (hr)
0 hr0 hr 6 hr6 hr 12 hr12 hr 24 hr24 hr 48 hr48 hr ControlControl 1.14±0.051.14 ± 0.05 2.3±0.082.3 ± 0.08 2.01±0.122.01 ± 0.12 1.70±0.051.70 ± 0.05 1.35±0.051.35 ± 0.05 감초추출물Licorice Extract 1.12±0.031.12 ± 0.03 2.06±0.03* 2.06 ± 0.03 * 1.80±0.041.80 ± 0.04 1.49±0.021.49 ± 0.02 1.18±0.071.18 ± 0.07 감초가수분해
추출물
Licorice Hydrolysis
extract
1.18±0.081.18 ± 0.08 2.11±0.01* 2.11 ± 0.01 * 1.75±0.06* 1.75 ± 0.06 * 1.40±0.02* 1.40 ± 0.02 * 1.20±0.06* 1.20 ± 0.06 *

Each data represents the mean ± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

Statistically significantly value compared with control group data by T test(*P<0.05, **P<0.01)Statistically significantly value compared with control group data by T test ( * P <0.05, ** P <0.01)

감초추출물, 감초가수분해추출물 및 트리암시놀론의 부종률은 12시간 후에 급격히 감소되었고 48시간까지 부종억제효과가 유지되었다.The edema rate of licorice extract, licorice hydrolyzate and triamcinolone decreased rapidly after 12 hours and the edema suppression effect was maintained until 48 hours.

한편 12시간 후 대조군에 대한 부종 억제율을 비교해 보면, 감초엑스에서 20.44%에 불과 하였으나 트리암시놀론에서 29.36%를 나타내었고 감초가수분해추출물에서는 36.7 %로 가장 높은 성적을 보여 주었으며, 48시간 후에 부종 억제율은 감초엑스가 70.91 %인 반면, 트리암시놀론이 85.83%, 감초가수분해추출물이 90.8%로 나타났다.In comparison, after 12 hours, the edema inhibition rate of the control group was only 20.44% in licorice extract, but 29.36% in triamcinolone and 36.7% in licorice hydrolyzate extract. While the X was 70.91%, the triamcinolone was 85.83% and the licorice hydrolyzed extract was 90.8%.

[그림3] 카라기난으로 유발된 흰쥐의 족부종에 대한 감초가수분해추출물의 억제효과[Figure 3] Inhibitory Effect of Licorice Hydrolyzate Extract on Carrageenan-Induced Foot Edema in Rats

Figure 112009002773147-pat00006
Figure 112009002773147-pat00006

(GR:감초엑스, GHT:감초가수분해추출물, TA:트리암시놀론)(GR: Licorice Extract, GHT: Licorice Hydrolyzate Extract, TA: Triamcinolone)

Each bar represents the mean± SE from 5 experiments.Each bar represents the mean ± SE from 5 experiments.

Statistically significantly value compared with GR group data by Statistically significantly value compared with GR group data by

Student's - t test (*P<0.05, **P<0.01, ***P<0.001). Student's- t test ( * P <0.05, ** P <0.01, *** P <0.001).

5. 진통효과 측정실험5. Analgesic effect measurement experiment

1) 열 통각 역치 측정실험1) Heat pain threshold measurement experiment

열 통각 역치는 민감성을 높인 새로운 열 통각 역치 측정 방법을 응용하여 실험하였다. 먼저 probe tip(프로브팁)의 직경 2mm인 Thermode (터모드, Quck-Korea704D, Quick Electonic Equipment Factory, Korea)를 50℃로 고정하여 흰쥐의 일차 통각과민대와 이차통각 과민대에 가볍게 접촉하여 회피반응이 일어나기까지의 시간을 측정하였다. 측정은 흰쥐의 열에 대한 적응을 위하여 30℃의 hot plate 위에서 10분간 적응시킨 후 실험하였으며, 5회 측정하여 평균값을 이용하였다. The heat pain threshold was tested by applying a new heat pain threshold measurement method with increased sensitivity. First, a thermode (Turmod, Quck-Korea704D, Quick Electonic Equipment Factory, Korea) with a diameter of 2 mm of the probe tip was fixed at 50 ° C to avoid the reaction by lightly contacting the primary hyperalgesia and secondary hyperalgesia of rats. The time until this occurred was measured. The measurement was performed after adapting the rats for 10 minutes on a hot plate at 30 ° C for adaptation to the heat of the rats.

측정은 통각과민 유발 전, 유발 후 3시간, 유발 후 6시간, 유발 후 9시간에 실시하였다.Measurements were performed before, 3 hours after induction, 6 hours after induction, and 9 hours after induction of hyperalgesia.

2) 기계적 통각 역치 측정 실험2) Mechanical pain threshold measurement experiment

기계적 통각 역치 측정은 급성압축방법에 의한 기계적 통각 역치 측정방법을 응용하여 실험하였다. 먼저 Von Frey filament(본 후레이 휠라멘트, North Coast Medical Inc., Touch-Test Sensory Evaluation, USA)를 이용하여 흰쥐의 회피 반사 유발 횟수를 측정하였다. 먼저 흰쥐를 대상으로 1.4, 2, 4, 6, 8, 10, 15, 26 g의 monofilament(모노필라멘트)를 사용하여 압력이 낮은 것부터 자극하여 최소 압통각의 일차 통각과민대와 이차통각과민대에 monofilament(모노필라멘트)의 끝이 접촉된 상태에서 약간 휘어질 정도의 압력으로 적용하였다. 총 5회 적용하여 회피반사가 일어나는 횟수를 측정하였으며, 흰쥐의 적응을 막기 위해 실험간 간격은 최소 2분으로 하였다. Mechanical pain threshold measurement was performed by applying mechanical pain threshold measurement by acute compression method. First, the number of incidence of avoidance reflex in rats was measured using Von Frey filament (Bon Frey Filament, North Coast Medical Inc., Touch-Test Sensory Evaluation, USA). First, the rats were stimulated with low pressure using 1.4, 2, 4, 6, 8, 10, 15, and 26 g monofilament, to the primary and secondary hyperalgesia with minimal tenderness. The pressure was applied slightly to the tip of the monofilament. The number of evasion reflections was measured by applying a total of five times, and the interval between experiments was at least 2 minutes to prevent the adaptation of rats.

측정은 통각과민 유발 전, 유발 후 3시간, 유발 후 6시간, 유발 후 9시간으로 실시하였다.The measurement was conducted before, 3 hours after induction, 6 hours after induction, and 9 hours after induction of hyperalgesia.

3) 유해성 굴곡 반사 측정 실험3) Hazard flexion reflection test

유해성 굴곡회피반사의 측정은 염증 동물 모델에서 전기적 신경 자극에 의한 유해성 굴곡 반사 측정 방법을 응용하여 실험하였다. 먼저 흰쥐를 ether(에테르)로 흡입 마취를 지속적으로 진행하면서 마취시킨 후 유해성 굴곡회피반사 활동전위는 한 쌍의 EL450 monopolar needle(모노폴라니들, Biopac system, USA)을 이용하여 흰쥐의 대퇴이두근에 삽입하고 EMG100C amplifier module(앰플리화이어모듈, Biopac system, USA)을 통하여 기록하였다. 접지전극은 꼬리에 부착하였다.The measurement of noxious flexion reflex was performed by applying the noxious flexion reflex measurement method by electrical nerve stimulation in inflammatory animal model. First, anesthetized rats with ether, followed by anesthesia, followed by anesthesia. Hazardous flexor reflex action potential was inserted into the femoral biceps of a rat using a pair of EL450 monopolar needles (Monopolar needle, Biopac system, USA). The EMG100C amplifier module (Amplifier module, Biopac system, USA) was used for recording. The ground electrode was attached to the tail.

STIM100C stimulator module(스티뮬리이터 모듈)과 STIMSOC(스팀속, Biopac system, USA)를 이용하여 한 쌍의 monopolar needle(모노폴라니들)을 통각과민 유발부위인 족저부에 삽입한 후 전기자극하여 회피반사가 유발되는 적기적 통각역치를 결정한 다음, 통각역치의 1.5배로 자극하여 근전도 모니터에서 유해성 굴곡회피반사 활동전위가 나타나면 저장하였다.Using a STIM100C stimulator module and STIMSOC (Seapac, Biopac system, USA), a pair of monopolar needles (monopolar needles) are inserted into the plantar feet of hyperalgesia. The timely pain threshold was induced, and then stimulated at 1.5 times the pain threshold and stored when the potential flexion reflex activity potential appeared on the EMG monitor.

활동전위를 기록하기 위한 조건은 high pass filter(하이패스휠터), 500Hz, low pass filter(로우패스휠터, 10Hz, gain(게인) 1000㎶, sample rate(쌤플레이트) 1000Hz, 하였고 noise voltage(노이즈볼티지)는 0.2㎶이었고 60Hz의 notch-filter(노치휠터)를 사용하였다. 검사자극은 단일 사각형파로 2ms 맥동기간으로 하였다. The conditions for recording the activity potential were high pass filter, 500 Hz, low pass filter (low pass filter, 10 Hz, gain 1000 Hz, sample rate 1000 Hz, noise voltage) Tage) was 0.2 Hz and a notch-filter (notch filter) of 60 Hz was used, and the test stimulus was a single square wave with a 2 ms pulsation period.

반응의 크기는 RMS(알엠에스, root mean squre, mV)로 구하였다. 유해성 굴곡회피반사의 기록과 분석은 Acknowledge(애크놀리지)3.8.1.Software program(3.8.1.소프트웨어프로그램)을 이용하였다. 측정은 통각과민 유발 전, 유발 후 9시간에 실시하였다.The size of the reaction was calculated by RMS (root mean squre, mV). The recording and analysis of hazard flexion reflexes were carried out using the Acknowledge 3.8.1.Software program. Measurements were made before and after the onset of hyperalgesia.

4) 진통효과 비교4) Comparison of analgesic effects

열통각역치의 변화는 대조군에 비해 모든 실험군에서 유의한 차이가 나타났으며, 유발 후 9시간 후에 대조약물인 트리암시놀론 및 감초추출물에서 25%정도의 진통억제효과가 나타났으며 감초가수분해추출물에서는 45%정도로 가장 좋은 성적을 보여주었다.Changes in the analgesia threshold were significantly different in all experimental groups compared to the control group. After 9 hours of induction, the control drugs of triamcinolone and licorice extract showed 25% analgesic inhibitory effect and 45% in licorice hydrolyzed extract. The best grade was shown in%.

[그림4] 흰쥐의 열통각 역치에 대한 감초가수분해추출물의 진통효과[Figure 4] Analgesic Effects of Licorice Hydrolyzate Extracts on the Threshold of Threshold in Rats

Figure 112009002773147-pat00007
Figure 112009002773147-pat00007

(GR:감초엑스, GHT:감초가수분해추출물, TA:트리암시놀론)(GR: Licorice Extract, GHT: Licorice Hydrolyzate Extract, TA: Triamcinolone)

Each bar represents the mean± SE from 5 experiments.Each bar represents the mean ± SE from 5 experiments.

Statistically significantly value compared with Blank group data by Student's - t test (*P<0.05, **P<0.01).Statistically significantly value compared with Blank group data by Student's- t test ( * P <0.05, ** P <0.01).

기계적 통각역치의 변화는 통증 유발 후 6시간 후부터 모든 실험군에서 대조 군에 비해 유의한 차이가 나타나기 시작하였으며, 9시간 후에는 대조약물인 트리암시놀론이 20%정도의 통증억제효과를 나타낸 반면 감초추출물에서 75%정도의 진통억제효과가 나타났고 감초가수분해추출물에서는 160%정도로 월등하게 높은 성적을 보여주었다.After 6 hours of pain-induced change in mechanical pain threshold, significant differences were observed in all experimental groups compared to the control group. After 9 hours, triamcinolone, a control drug, showed about 20% pain suppression effect while 75 in licorice extract. Analgesic inhibitory effect was about%, and licorice hydrolyzed extract showed a much higher score (160%).

[그림5] 흰쥐의 기계적 통각 역치에 대한 감초가수분해추출물의 진통효과[Figure 5] Analgesic Effect of Licorice Hydrolyzate Extract on Mechanical Pain Threshold in Rats

Figure 112009002773147-pat00008
Figure 112009002773147-pat00008

(GR:감초엑스, GHT:감초가수분해추출물, TA:트리암시놀론)(GR: Licorice Extract, GHT: Licorice Hydrolyzate Extract, TA: Triamcinolone)

Statistically significantly value compared with Blank group data by Student's- t test (*P<0.05, **P<0.01). Statistically significantly value compared with Blank group data by Student's- t test (* P <0.05, ** P <0.01).

염증 동물 모델에서 전기적 신경자극에 의한 유해성 굴곡반사 반응시간에 변하는 9시간 후에 대조군에서 69.19밀리볼트인 반면 대조약물인 트리암시놀론에서는 41.39밀리볼트, 감초추출물에서 40.15밀리볼트, 감초가수분해추출물에서는 40.46밀 리볼트로 나타나 모든 군에서 유의성있는 수치를 보여주었으며 실험군간의 차이는 별로 크게 나타나지 않았다.Inflammatory animal models were 69.19 millivolts in the control group after 9 hours of change in adverse flexion response time due to electrical neurostimulation, 41.39 millivolts in the control triamcinolone, 40.15 millivolts in the licorice extract, and 40.46 millivolts in the licorice hydrolyzed extract All groups showed significant values, and the differences between the experimental groups were not significant.

[표5][Table 5]

흰쥐의 유해성굴곡 회피반사의 반응시간에 대한 감초가수분해추출물의 진통효과Analgesic Effect of Licorice Hydrolyzate Extract on Response Time of Hazardous Flexion Avoidance in Rats

prepre 9h9h BlankBlank 37.0337.03 69.1969.19 감초추출물Licorice Extract 33.8433.84 40.15*** 40.15 *** 트리암시놀론Triamcinolone 33.733.7 41.39*** 41.39 *** 감초가수분해추출물Licorice Hydrolyzate Extract 38.8338.83 40.46*** 40.46 ***

Each data represents the mean± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

Statistically significantly value compared with Blank group data by Student's - t test (***P<0.001). Statistically significantly value compared with Blank group data by Student's- t test ( *** P <0.001).

한편 유해성 굴곡회피반사의 실효치 진폭변화는 통증유발 후 9시간 후에 대조군에서 0.45초로 나타난 반면 트리암시놀론에서 0.41초, 감초추출물 및 감초가수분해추출물에서는 모두 0.36초로 나타났다.On the other hand, the change in effective amplitude of harmful bend reflex was 0.45 seconds in the control group 9 hours after pain induction, while 0.41 seconds in triamcinolone, and 0.36 seconds in licorice extract and licorice hydrolyzed extract.

[표6] Table 6

흰쥐의 유해성굴곡 회피반사의 실효치 진폭변화에 대한 감초가수분해추출물의 진통효과Analgesic Effects of Licorice Hydrolyzate Extracts on the Amplitude Variation of Effective Value of Hazardous Flexion Avoidance in Rats

prepre 9h9h BlankBlank 0.410.41 0.450.45 감초추출물Licorice Extract 0.350.35 0.36* 0.36 * 트리암시놀론Triamcinolone 0.380.38 0.410.41 감초가수분해추출물Licorice Hydrolyzate Extract 0.350.35 0.36* 0.36 *

Each data represents the mean± SE from 5 experiments.Each data represents the mean ± SE from 5 experiments.

Statistically significantly value compared with Blank group data by Student's - t test (*P<0.05). Statistically significantly value compared with Blank group data by Student's- t test ( * P <0.05).

Claims (5)

감초 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of licorice, add 500 milliliters of 70% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ° C in a water bath, filter with filter paper, and collect the filtrate. 300 ml of purified water and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃; 인삼 600그램에 70% 알코올 800밀리리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 400밀리리터 및 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;800 ml of 70% alcohol and 40 milliliters of 1% hydrochloric acid were added to 600 g of ginseng, warmed at 50-60 ℃ for 4 hours in a water bath, filtered through a filter paper, and the filtrate was collected. 400 ml of purified water and enzyme solution Adding 20 milliliters and fermenting at 28-32 ° C. for 30 days; 복령 1.0킬로그램에 70% 알코올 1.2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 800밀리리터 및 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;1.2 kg of 70% alcohol and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, heated in a water bath at 50-60 ° C. for 4 hours, filtered through a filter paper, and the filtrate was taken. 800 ml of purified water and an enzyme solution were obtained. Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days; 생지황 1.6킬로그램에 70% 알코올 2.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 1리터 및 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kilograms of raw sulfur, 2.2 liters of 70% alcohol and 110 milliliters of 1% hydrochloric acid were added, heated at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 1 liter of purified water and an enzyme solution 50 milliliters of the fermentation for 30 days at 28 ~ 32 ℃; 생강 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, 500 ml of 70% alcohol and 25 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was collected. 300 ml of purified water and enzyme solution 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃; 대조 400그램에 70% 알코올 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 정제수 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;500 milliliters of 70% alcohol and 25 milliliters of 1% hydrochloric acid were added to 400 grams of control. The mixture was warmed at 50 to 60 DEG C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was collected. 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃; 위에서 각각 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 하는 것을 특징으로 하는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법.Licorice, Ginseng, Bokyeong, Saenghwanghwang, Ginger, and the control solution, each extracted and fermented with alcohol solution from above, are mixed in one container and warmed at 80-90 ℃ for 4 hours in a water bath to completely volatilize the alcohol components, A method for producing a concentrated syrup for internal use containing a hydrolyzed extract of licorice and the complex herbal, characterized in that the concentrate is filled into an airtight container to produce a final product. 제 1항에 있어서, The method of claim 1, 상기 효소용액은 β-glucuronidase(베타글루쿠로니다제)50,000unit(역가)를 취하고 정제수를 넣어 100밀리리터로 구비되는 것을 특징으로 하는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법.The enzyme solution β-glucuronidase (betaglucuronidase) A method for producing concentrated syrup for internal use containing hydrolyzed extracts of licorice and its complex herbal medicine, characterized in that it is prepared in 100 milliliters by taking 50,000 units (titer) of purified water. 감초 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of licorice, add 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ℃ in a water bath, filter with filter paper, and take the filtrate. 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃; 인삼 600그램에 35% 알코올 1.2리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;Add 1.2 liters of 35% alcohol and 40 milliliters of 1% hydrochloric acid to 600 grams of ginseng, warm for 4 hours at 50-60 ℃ in a water bath, filter with filter paper, take filtrate, add 20 milliliters of enzyme solution, and add 30 ml at 28-32 ℃ for 30 days. Fermentation during; 복령 1.0킬로그램에 35% 알코올 2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;2 kg of 35% alcohol and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days; 생지황 1.6킬로그램에 35% 알코올 3.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kilograms of raw sulfur, 3.2 liters of 35% alcohol and 110 milliliters of 1% hydrochloric acid were added and warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, filtrate was added 50 ml of enzyme solution, and 30 days at 28 to 32 ° C. Fermentation during; 생강 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, add 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ℃ in a water bath, filter with filter paper, take filtrate, add 15 milliliters of enzyme solution, and add 30ml at 28-32 ℃. Fermentation during; 대조 400그램에 35% 알코올 800밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of control, 800 milliliters of 35% alcohol and 25 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 15 milliliters of fermentation for 30 days at 28 ~ 32 ℃; 위에서 각각 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 하는 것을 특징으로 하는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법.Licorice, Ginseng, Bokyeong, Saenghwanghwang, Ginger, and the control solution, each extracted and fermented with alcohol solution from above, are mixed in one container and warmed at 80-90 ℃ for 4 hours in a water bath to completely volatilize the alcohol components, A method for producing a concentrated syrup for internal use containing a hydrolyzed extract of licorice and the complex herbal, characterized in that the concentrate is filled into an airtight container to produce a final product. 제 1항에 있어서, The method of claim 1, 상기 효소용액은 β-glucuronidase(베타글루쿠로니다제)50,000unit(역가)를 취하고 정제수를 넣어 100밀리리터로 구비되는 것을 특징으로 하는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법.The enzyme solution β-glucuronidase (betaglucuronidase) A method for producing concentrated syrup for internal use containing hydrolyzed extracts of licorice and its complex herbal medicine, characterized in that it is prepared in 100 milliliters by taking 50,000 units (titer) of purified water. 감초 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계; To 400 grams of licorice, add 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid, warm for 4 hours at 50-60 ° C in a water bath, filter with filter paper, filter the filtrate, add 300 milliliters of 95% alcohol and 15 milliliters of enzyme solution. Fermentation at 30 ° C. for 30 days; 인삼 600그램에 정제수 800밀리리터 및 1% 염산 40밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 400밀리리터 및 효소용액 20밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;Add 800 milliliters of purified water and 40 milliliters of 1% hydrochloric acid to 600 grams of ginseng, warm it for 4 hours in a water bath at 50-60 ℃, filter it with a filter paper, take a filtrate, add 400 milliliters of 95% alcohol and 20 milliliters of enzyme solution. Fermentation at 30 ° C. for 30 days; 복령 1.0킬로그램에 정제수 1.2리터 및 1% 염산 60밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 800밀리리터 및 효소용액 40밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;1.2 kg of purified water and 60 milliliters of 1% hydrochloric acid were added to 1.0 kg of Bokryeong, warmed at 50-60 ° C for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 800 ml of 95% alcohol and enzyme solution Adding 40 milliliters and fermenting at 28-32 ° C. for 30 days; 생지황 1.6킬로그램에 정제수 2.2리터 및 1% 염산 110밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 1리터 및 효소용액 50밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 1.6 kilograms of fresh sulfur, 2.2 liters of purified water and 110 milliliters of 1% hydrochloric acid were added, heated at 50 to 60 ° C. for 4 hours in a water bath, filtered through a filter paper, and the filtrate was taken. 1 liter of 95% alcohol and an enzyme solution 50 milliliters of the fermentation for 30 days at 28 ~ 32 ℃; 생강 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of ginger, 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid were added, heated at 50-60 ° C. for 4 hours in a water bath, filtered through a filter paper, and filtrate was collected. 300 ml of 95% alcohol and 15 milliliters of enzyme solution were added. Fermentation at 30 ° C. for 30 days; 대조 400그램에 정제수 500밀리리터 및 1% 염산 25밀리리터를 가하여 수욕 상에서 50~60℃로 4시간동안 가온하고 여과지로 여과한 후 여액을 취하여 95% 알코올 300밀리리터 및 효소용액 15밀리리터를 넣고 28~32℃에서 30일 동안 발효시키는 단계;To 400 grams of control, 500 milliliters of purified water and 25 milliliters of 1% hydrochloric acid were added, warmed at 50 to 60 ° C for 4 hours in a water bath, filtered through a filter paper, and filtrate was taken. 300 ml of 95% alcohol and 15 milliliters of enzyme solution were added. Fermentation at 30 ° C. for 30 days; 위에서 각각 정제수 및 알코올용액으로 추출하고 발효시킨 감초, 인삼, 복령, 생지황, 생강 및 대조액을 모두 한 용기에 혼합하고 수욕 상에서 80~90℃로 4시간동안 가온하여 알코올 성분을 완전히 휘발시킨 다음 남아있는 생약 복합 농축물을 기밀용기에 충전하여 최종 제조물로 하는 것을 특징으로 하는 감초 및 그 복합생약의 가수분해 추출물을 함유하는 내복용의 농축시럽 제조방법.Licorice, Ginseng, Bokryeong, Saengjihwang, Ginger, and the control solution, which were extracted and fermented with purified water and alcohol solution from above, were all mixed in one container and warmed at 80-90 ° C. for 4 hours in a water bath to completely evaporate the remaining alcohol. A method for producing a concentrated syrup for internal use containing a licorice and a hydrolyzed extract of the complex herbal, characterized by filling the herbicidal complex concentrate in an airtight container to produce a final product.
KR1020090003498A 2009-01-15 2009-01-15 prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines KR101038510B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090003498A KR101038510B1 (en) 2009-01-15 2009-01-15 prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090003498A KR101038510B1 (en) 2009-01-15 2009-01-15 prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines

Publications (2)

Publication Number Publication Date
KR20100084069A KR20100084069A (en) 2010-07-23
KR101038510B1 true KR101038510B1 (en) 2011-06-01

Family

ID=42643604

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090003498A KR101038510B1 (en) 2009-01-15 2009-01-15 prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines

Country Status (1)

Country Link
KR (1) KR101038510B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220087716A (en) 2020-12-18 2022-06-27 대한민국(농촌진흥청장) Licorice extract with increased skin whitening functional ingredients by high temperature treatment and its manufacturing method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101134089B1 (en) * 2011-04-15 2012-04-13 함양군 Syrup process using acer mono max liquid and mountaingrown ginseng
CN102716308B (en) * 2012-06-28 2014-02-26 陈慧婷 Tarragon Chinese herbal preparation for treating tympanites and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050108415A (en) * 2003-03-27 2005-11-16 마쓰우라 야쿠교 가부시키가이샤 Galenical-extract-blended liquid medicine pack

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050108415A (en) * 2003-03-27 2005-11-16 마쓰우라 야쿠교 가부시키가이샤 Galenical-extract-blended liquid medicine pack

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220087716A (en) 2020-12-18 2022-06-27 대한민국(농촌진흥청장) Licorice extract with increased skin whitening functional ingredients by high temperature treatment and its manufacturing method

Also Published As

Publication number Publication date
KR20100084069A (en) 2010-07-23

Similar Documents

Publication Publication Date Title
EP2278986B1 (en) A product for topical administration
US20020071868A1 (en) Multicomponent biological vehicle
CN108272862B (en) Pudilan oral spray and preparation method thereof
US9907824B2 (en) Stable formulations
CN108704021A (en) The composition and preparation method impaired for skin allergy and skin barrier
KR101382115B1 (en) Health food for improving atopic dermatitis and xerosis containing ginseng fruit extracts
KR101038510B1 (en) prepartaion of concentrated syrups for oral use containing hydrolyzed products of Glycyrrhizae Radix extracts and its compounding herbal medicines
KR20060087134A (en) Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same
JP6820323B2 (en) Composition and its use
KR102075849B1 (en) Composition for skin moisturizing and anti-inflammation and enhancing skin barrier comprising Aureobasidium pullulans extract as effective component
CN109589400B (en) Composition with neuroprotective effect
KR101160088B1 (en) Herbal extracts composition for the prevention of alcoholic fatty liver, hyperlipidemia and hangover
Bauer Chemistry, pharmacology and clinical applications of Echinacea products
KR100902679B1 (en) Prepartaion of concentrated syrups for oral use containing alcohol fermentated extracts of zingiberis rhizoma and its compounding herbal medicines
CN102973657B (en) Cough-relieving Qinbaohong mixture and preparation method thereof
Grover et al. Protective effect of coadministration of Cassia auriculata and pioglitazone in diabetic rats
CN110063977B (en) Radix codonopsis and sea buckthorn composite electuary and application thereof
CN106880654B (en) Application of panax japonicus extract in preparing medicine for treating rhinitis and composition
CN109908109A (en) A kind of anti-inflammatory analgesic emplastrum and preparation method thereof
Chen et al. Anti-fatigue effect of aqueous extract of Anisomeles indica (L) Kuntze in mice
KR20050079913A (en) Hovenia dulcis extract for treatment of obesity
CN116211993B (en) Composition for treating senile chronic disease and its preparation method
Naseem et al. The effects of Panax ginseng root extract on carbohydrate and lipid disturbances associated with alloxan-induced diabetic rats.
Bauer et al. Echinacea purpurea
CN116036174B (en) Medicine for treating pulmonary nodules and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140307

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160318

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee